A History of Measles

• Introduction
• Chapter 1 The Origins of Measles: From Rinderpest to Human Disease
• Chapter 2 Early Encounters: Measles in Ancient and Medieval Societies
• Chapter 3 Rhazes and the First Scientific Description of Measles
• Chapter 4 Measles Spreads: Trade, Exploration, and Colonialism
• Chapter 5 The Pathogen Revealed: Understanding Viral Transmission
• Chapter 6 Measles in Isolated Populations: Catastrophic Outbreaks
• Chapter 7 A Global Disease: Measles in the Modernizing World
• Chapter 8 Measles in the United States: The Notifiable Era
• Chapter 9 The Toll Before Vaccination: Illness, Mortality, and Complications
• Chapter 10 The Virus Itself: Structure, Transmission, and Immunology
• Chapter 11 Pioneering Research: Isolating the Measles Virus
• Chapter 12 The Edmonston Strain: Foundations of Vaccine Development
• Chapter 13 The First Vaccine: Trials, Triumphs, and Challenges
• Chapter 14 Maurice Hilleman and the Next Generation of Vaccines
• Chapter 15 The MMR Vaccine: A Combined Approach to Prevention
• Chapter 16 Elimination Campaigns: The WHO and the Global Response
• Chapter 17 Measles in Decline: Successes and Setbacks by Region
• Chapter 18 The Second Dose: Policy Changes and Their Impact
• Chapter 19 Eliminating Measles in the Americas and Beyond
• Chapter 20 Resurgences and Obstacles: Vaccine Hesitancy and Misinformation
• Chapter 21 Global Disparities: Access and Equity in Vaccination
• Chapter 22 The Role of Surveillance: Detecting and Containing Outbreaks
• Chapter 23 The COVID-19 Pandemic: New Challenges for Measles Control
• Chapter 24 Eradication or Control: The Debate and the Future Path
• Chapter 25 Toward a World Without Measles: Sustaining Progress and Hope

Measles has shaped the course of human history in profound, if often tragic, ways. For centuries, this highly contagious viral infection has swept through communities large and small, sparking outbreaks that have cost millions of lives and left lasting scars on populations and cultures. Its story is deeply intertwined with the rise of cities, the movement of people, and the evolution of medicine itself.

The roots of measles reach back into antiquity, with tantalizing evidence suggesting its ancestors may have haunted human societies as far back as the classical era. The first systematic descriptions emerged during the Islamic Golden Age in the works of Persian physicians, who painstakingly distinguished measles from other devastating diseases like smallpox. As human populations grew and global connections widened, measles took on pandemic qualities, seeding itself wherever people clustered together—often with catastrophic results for naïve, unexposed communities.

For generations, measles was seen as an inevitable rite of passage, targeting mostly children and leaving few families untouched. The clinical burden could be overwhelming: not only the characteristic fever and rash, but a litany of potentially severe and fatal complications, including pneumonia, encephalitis, blindness, and, in some cases, delayed but deadly neurological decline. Historians estimate that measles has claimed the lives of hundreds of millions over its long reign.

But the story of measles is not one of unbroken suffering. It is also a saga of scientific discovery, collaboration, and public health achievement. The identification of the virus at the dawn of the modern era, and the subsequent development of the live-attenuated vaccine, stand as milestones in the field of vaccinology. These efforts have transformed measles from an ever-present threat to a largely preventable disease—at least where access to vaccines is widespread and public trust in immunization remains strong.

Yet, as recent years have shown, the fight against measles is not over. Outbreaks continue to flare, driven by gaps in coverage, vaccine hesitancy, political instability, and weaknesses in healthcare infrastructure. The COVID-19 pandemic wrought new setbacks, exposing the fragility of global immunization progress. While the elimination of measles remains tantalizingly within reach, sustained vigilance, innovation, and international cooperation are more crucial than ever.

This book charts the remarkable journey of measles through history: from its ancient origins and early descriptions, through its deadly sweeps across continents, to the breakthroughs of modern biomedicine and the continuing struggle for global eradication. In exploring this saga, we also reflect on timeless themes in public health—the power and limits of science, the complex interplay between disease and society, and the enduring hope that one day, measles will be relegated at last to the annals of history.

To understand measles, one must first look to its ancient origins, a story that intertwines human civilization with the diseases of the animal kingdom. Measles did not simply appear out of thin air; it evolved, a viral descendant of a formidable bovine pathogen known as rinderpest. Rinderpest, a highly infectious viral disease of cattle and other hoofed animals, was a scourge on livestock for centuries, causing immense economic devastation and famine. But somewhere along the winding path of evolution, a version of this animal virus found a new host in humans.

The transition from an animal disease to a human one, a phenomenon known as zoonotic spillover, is not uncommon in the history of infectious diseases. It often occurs when humans and animals live in close proximity, creating opportunities for pathogens to jump between species. The agricultural revolution, beginning around 10,000 BCE, brought humans into unprecedented contact with domesticated animals, including cattle. This close cohabitation provided ample opportunities for the rinderpest virus to make the leap.

While a precursor to measles may have sporadically infected humans as early as the 4th century BCE, the full divergence of the measles virus from its rinderpest ancestor is believed to have occurred later. Genomic analyses, which scrutinize the genetic makeup of viruses, have been instrumental in tracing this evolutionary lineage. Some research suggests this divergence could have happened as far back as the 6th century BCE, coinciding with a period of significant urban growth. Other analyses have placed the divergence at the end of the 9th century CE, with a more commonly cited timeframe for the full divergence falling between 1100 and 1200 AD. This latter period aligns with the growth of medieval European cities to populations large enough, exceeding 500,000 inhabitants, to sustain measles epidemics.

The concept of a "critical community size" is vital here. For a highly contagious disease like measles to become endemic, meaning continuously present within a population, it requires a sufficiently large and interconnected group of susceptible individuals. In smaller, more dispersed populations, an outbreak might burn through susceptible individuals quickly and then die out, unable to find new hosts. However, as cities swelled in size during the first millennium BCE and into the medieval period, they provided the ideal conditions for a human-specific measles virus to take hold and persist. This was a significant evolutionary step, transforming a sporadic animal-to-human jump into a sustained human-to-human transmission cycle.

The process wasn't instantaneous; it was a gradual evolution. As the rinderpest virus adapted to its new human hosts, genetic mutations occurred, slowly transforming it into the distinct human measles virus we know today, or Measles morbillivirus (MeV). This new virus retained the highly contagious nature of its ancestor but developed a specific affinity for human cells, becoming an exclusively human pathogen. The emergence of measles from rinderpest serves as a compelling example of how human societal changes—specifically, the development of settled agricultural communities and large urban centers—can profoundly influence the emergence and evolution of new human diseases.